The company has developed imaging software which Leica Microsystems's biosystems division will adapt to its product portfolio to support the work of its pathology customers.
At the end of 2007, Leica Microsystems acquired Cell Analysis, based in Chicago, IL, USA.
The Cell Analysis software system quantifies staining in tumour cells enabling pathologists to make precise diagnoses.
This imaging software is used with a microscope in the histopathological workflow following advanced staining, for instance, by the Leica Bond system.
The software was developed by two pathologists working closely with the Cell Analysis CEO.
Leica Microsystems is a global designer and producer of innovative, high-tech, precision optical systems for the analysis of microstructures.
It claims to be one of the market leaders in each of its business areas: microscopy, confocal laser scanning microscopy with corresponding imaging systems, specimen preparation, and medical equipment.
The company manufactures a broad range of products for numerous applications requiring microscopic imaging, measurement, and analysis.
It also offers system solutions for life science including biotechnology and medicine, research and development of raw materials, and industrial quality assurance.
The company is represented in over 100 countries with nine manufacturing facilities in seven countries, sales and service organizations in 19 countries and an international network of dealers.
The international management is headquartered in Wetzlar, Germany.
